ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

SGMT Sagiment Biosciences Inc

4.82
0.12 (2.55%)
25 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Sagiment Biosciences Inc SGMT 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.12 2.55% 4.82 05:40:20
개장가 저가 고가 종가 전일 종가
4.79 4.60 4.91 4.82 4.70
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
23/05/202420:00EDGAR2Form 8-K - Current report
15/05/202421:05EDGAR2Form 8-K - Current report
15/05/202420:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/05/202405:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/05/202405:05EDGAR2Form 3 - Initial statement of beneficial ownership of..
06/05/202421:06EDGAR2Form 8-K - Current report
25/03/202420:00GLOBESagimet Biosciences Announces Appointment of Tim Walbert and..
25/03/202419:15GLOBESagimet Biosciences Reports Full Year 2023 Financial Results..
29/02/202422:00GLOBESagimet Biosciences to Participate in Two Upcoming Investor..
15/02/202408:10EDGAR2Form SC 13G - Statement of acquisition of beneficial..
15/02/202406:37EDGAR2Form SC 13G - Statement of acquisition of beneficial..
06/02/202406:34EDGAR2Form SC 13G - Statement of acquisition of beneficial..
03/02/202406:36EDGAR2Form 8-K - Current report
03/02/202406:05EDGAR2Form 3 - Initial statement of beneficial ownership of..
01/02/202406:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/02/202406:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/01/202406:05EDGAR2Form 8-K - Current report
26/01/202414:15EDGAR2Form EFFECT - Notice of Effectiveness
26/01/202410:58GLOBESagimet Biosciences Announces Pricing of Public Offering of..
24/01/202420:10EDGAR2Form 8-K - Current report
24/01/202420:08EDGAR2Form S-1/A - General form for registration of securities..
24/01/202407:45GLOBESagimet Biosciences Announces Proposed Public Offering of..
24/01/202407:31EDGAR2Form S-1 - General form for registration of securities under..
22/01/202422:00EDGAR2Form 8-K - Current report
22/01/202421:00GLOBESagimet Biosciences Announces Positive Topline Results from..
30/12/202306:16EDGAR2Form 8-K - Current report
09/12/202306:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202322:00GLOBESagimet Biosciences to Participate in the First Annual..
28/11/202322:00GLOBESagimet Biosciences Announces Oral Presentation of..
22/11/202322:00GLOBESagimet Biosciences to Present at the 35th Annual Piper..
22/11/202306:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/11/202306:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/11/202311:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202322:40EDGAR2Form 8-K - Current report
13/11/202322:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202322:00GLOBESagimet Biosciences Reports Third Quarter 2023 Financial..
10/11/202322:30GLOBESagimet Biosciences Presents Preclinical Results Supporting..
25/10/202300:00GLOBESagimet Biosciences Announces Acceptance of Two Abstracts at..
23/10/202321:00EDGAR2Form 8-K - Current report
19/10/202305:05GLOBESagimet Biosciences To Present at the H.C. Wainwright 7th..
28/09/202305:32EDGAR2Form 8-K - Current report
28/09/202305:05GLOBESagimet Biosciences Announces Completion of Enrollment of..
09/09/202305:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/08/202305:09EDGAR2Form 8-K - Current report
22/08/202305:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
22/08/202305:02GLOBESagimet Biosciences Reports Second Quarter 2023 Financial..
16/08/202305:04GLOBESagimet Biosciences Announces Closing of Underwriters’..
10/08/202321:14EDGAR2Form 8-K - Current report
21/07/202305:05GLOBESagimet Biosciences Announces Leadership Changes
14/07/202310:10GLOBESagimet Biosciences Announces Pricing of Upsized Initial..

최근 히스토리

Delayed Upgrade Clock